Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model

被引:81
作者
Pawlinski, R
Pedersen, B
Kehrle, B
Aird, WC
Frank, RD
Guha, M
Mackman, N
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Beth Israel Deaconess Med Ctr, Mol Med Unit, Boston, MA 02215 USA
关键词
D O I
10.1182/blood-2002-07-2303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In septic shock, tissue factor (TF) activates blood coagulation, and cytokines and chemokines orchestrate an inflammatory response. In this study, the role of Egr-1 in lipopolysaccharide (LPS) induction of TF and inflammatory mediators in vivo was evaluated using Egr-1(+/+) and Egr-1(-/-) mice. Ad. ministration of LPS transiently increased the steady-state levels of Egr-1 mRNA in the kidneys and lungs of Egr-1(+/+) mice with maximal induction at one hour. Egr-1 was expressed in epithelial cells in the kidneys and lungs in untreated and LPS-treated mice. LPS induction of monocyte chemoattractant protein mRNA in the kidneys and lungs of Egr-1(-/-) mice was not affected at 3 hours, but its expression was significantly reduced at 8 hours compared with the expression observed in Egr-1(+/+) mice. Similarly, LIPS Induction of TF mRNA expression in the kidneys and lungs at 8 hours was reduced 16 Egr-1 mice. However, Egr-1 deficiency did not affect plasma levels of tumor necrosis factor a. in endotoxemic mice. Moreover, Egr-1(+/+) and Egr-1(-/-) mice exhibited similar survival times in a model of acute endotoxemia. these data indicate that Egr-1 does not contribute to the early inflammatory response in the kidneys and lungs or the early systemic inflammatory response in endotoxemic mice. However, Egr-1 does contribute to the sustained expression of Inflammatory mediators and to the maximal expression of TF at 8 hours in the kidneys and lungs. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3940 / 3947
页数:8
相关论文
共 51 条
[41]  
TAYLOR FB, 1991, CIRC SHOCK, V33, P127
[42]   Innate immune recognition of bacterial lipopolysaccharide: Dependence on interactions with membrane lipids and endocytic movement [J].
Thieblemont, N ;
Thieringer, R ;
Wright, SD .
IMMUNITY, 1998, 8 (06) :771-777
[43]   Coagulation inhibitor replacement in sepsis is a potentially useful clinical approach [J].
Thijs, LG .
CRITICAL CARE MEDICINE, 2000, 28 (09) :S68-S73
[44]   Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice [J].
Topilko, P ;
Schneider-Maunoury, S ;
Levi, G ;
Trembleau, A ;
Gourdji, D ;
Driancourt, MA ;
Rao, CV ;
Charnay, P .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (01) :107-122
[45]   In vivo expression of toll-like receptor 2 and 4 by renal epithelial cells:: IFN-γ and TNF-α mediated up-regulation during inflammation [J].
Wolfs, TGAM ;
Buurman, WA ;
van Schadewijk, A ;
de Vries, B ;
Daemen, MARC ;
Hiemstra, PS ;
van't Veer, C .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1286-1293
[46]   LEUKOCYTOSIS AND RESISTANCE TO SEPTIC SHOCK IN INTERCELLULAR-ADHESION MOLECULE 1-DEFICIENT MICE [J].
XU, H ;
GONZALO, JA ;
STPIERRE, Y ;
WILLIAMS, IR ;
KUPPER, TS ;
COTRAN, RS ;
SPRINGER, TA ;
GUTIERREZRAMOS, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :95-109
[47]   Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator [J].
Yamamoto, K ;
Loskutoff, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2440-2451
[48]   Egr-1: is it always immediate and early? [J].
Yan, SF ;
Pinsky, DJ ;
Mackman, N ;
Stern, DM .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (05) :553-554
[49]   Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress [J].
Yan, SF ;
Fujita, T ;
Lu, JS ;
Okada, K ;
Zou, YS ;
Mackman, N ;
Pinsky, DJ ;
Stern, DM .
NATURE MEDICINE, 2000, 6 (12) :1355-1361
[50]   Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells - Regulation by Egr-1, c-Jun, and NF-kappa B transcription factors [J].
Yao, J ;
Mackman, N ;
Edgington, TS ;
Fan, ST .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (28) :17795-17801